Register Now for ICER’s Tuesday Webinar on Myasthenia Gravis Therapies
August 23, 2021
The Institute for Clinical and Economic Review (ICER) will hold a webinar on Tuesday, August 24th at 2:00 PM ET. President Steve Pearson will discuss preliminary findings for two drugs intended to treat myasthenia gravis, efgartigimod and eculizumab. The webinar is part of a series illustrating the role of ICER Analytics in decision-making, as well as highlighting the FormularyDecisions healthcare platform.
“ICER’s Early Insights Webinar Series provides early insights into ongoing ICER research, and demonstrates how ICER Analytics™ helps health care decision makers use this research in new ways to develop formularies, negotiate drug prices, and ultimately, pursue policies that promote fair pricing and fair access.” Register here.
(Source: ICER, 2021)